Wang L, Wang FS, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278(4):369–95.

Article  CAS  PubMed  Google Scholar 

Pereira AC, Oliveira J, Silva S, Madeira N, Pereira CMF, Cruz MT. Inflammation in Bipolar Disorder (BD): identification of new therapeutic targets. Pharmacol Res. 2021;163:105325.

Article  CAS  PubMed  Google Scholar 

Fariduddin MM, Singh G. Thyroiditis. StatPearls: Treasure Island; 2022.

Google Scholar 

Sayana P, Colpo GD, Simoes LR, Giridharan VV, Teixeira AL, Quevedo J, Barichello T. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. J Psychiatr Res. 2017;92:160–82.

Article  PubMed  Google Scholar 

Noel N, Bernard R, Wechsler B, Resche-Rigon M, Depaz R, Le Thi Huong Boutin D, Piette JC, Drier A, Dormont D, Cacoub P, et al. Long-term outcome of neuro-Behcet’s disease. Arthritis Rheumatol. 2014;66(5):1306–14.

Article  PubMed  Google Scholar 

Hauben M. Cyclosporine neurotoxicity. Pharmacotherapy. 1996;16(4):576–83.

CAS  PubMed  Google Scholar 

Scully JL, Otten U. Glucocorticoids, neurotrophins and neurodegeneration. J Steroid Biochem Mol Biol. 1995;52(5):391–401.

Article  CAS  PubMed  Google Scholar 

Sole B, Jimenez E, Torrent C, Reinares M, Bonnin CDM, Torres I, Varo C, Grande I, Valls E, Salagre E, et al. Cognitive impairment in bipolar disorder: treatment and prevention strategies. Int J Neuropsychopharmacol. 2017;20(8):670–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cyrino LAR, Delwing-de Lima D, Ullmann OM, Maia TP. Concepts of neuroinflammation and their relationship with impaired mitochondrial functions in bipolar disorder. Front Behav Neurosci. 2021;15:609487.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen M, Jiang Q, Zhang L. The prevalence of bipolar disorder in autoimmune disease: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(1):350–61.

Article  PubMed  Google Scholar 

Wang LY, Chiang JH, Chen SF, Shen YC. Systemic autoimmune diseases are associated with an increased risk of bipolar disorder: a nationwide population-based cohort study. J Affect Disord. 2018;227:31–7.

Article  PubMed  Google Scholar 

Barbosa IG, Ferreira RA, Rocha NP, Mol GC, da Mata ChiaccjioLeite F, Bauer IE, Teixeira AL. Predictors of cognitive performance in bipolar disorder: The role of educational degree and inflammatory markers. J Psychiatr Res. 2018;106:31–7.

Article  PubMed  Google Scholar 

Reginia A, Kucharska-Mazur J, Jablonski M, Budkowska M, Dolegowska B, Sagan L, Misiak B, Ratajczak MZ, Rybakowski JK, Samochowiec J. Assessment of complement cascade components in patients with bipolar disorder. Front Psychiatry. 2018;9:614.

Article  PubMed  PubMed Central  Google Scholar 

Hamdani N, Bengoufa D, Godin O, Doukhan R, Le Guen E, Daban-Huard C, Bennabi M, Delavest M, Lepine JP, Boukouaci W, et al. Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection. BMC Psychiatry. 2018;18(1):239.

Article  PubMed  PubMed Central  Google Scholar 

Cuomo A, Koukouna D, Spiti A, Barilla G, Goracci A, Bolognesi S, Fagiolini A. Biomarkers, inflammation, and bipolar disorder: association between the improvement of bipolar disorder severity and the improvement in C-Reactive protein levels after 7 days of inpatient treatment. Front Psychiatry. 2021;12:803034.

Article  PubMed  PubMed Central  Google Scholar 

Edberg D, Hoppensteadt D, Walborn A, Fareed J, Sinacore J, Halaris A. Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. J Psychiatr Res. 2018;102:1–7.

Article  PubMed  Google Scholar 

Gorgulu Y, Uluturk MK, Palabiyik O. Comparison of serum BDNF, IL-1beta, IL-6, TNF-alpha, CRP and leucocyte levels in unipolar mania and bipolar disorder. Acta Neuropsychiatr. 2021;33(6):317–22.

Article  PubMed  Google Scholar 

Ghafouri-Fard S, Oskooei VK, Omrani MD, Taheri M. Dysregulation of cytokine coding genes in peripheral blood of bipolar patients. J Affect Disord. 2019;256:578–83.

Article  CAS  PubMed  Google Scholar 

Huang MH, Chen MH, Chan YE, Li CT, Tsai SJ, Bai YM, Su TP. Pro-inflammatory cytokines and suicidal behavior among patients with bipolar I disorder. J Psychiatr Res. 2022;150:346–52.

Article  PubMed  Google Scholar 

Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S. Cytokines in Behcet’s disease. J Rheumatol. 1996;23(2):321–2.

CAS  PubMed  Google Scholar 

Lambrecht BN, Hammad H, Fahy JV. The cytokines of asthma. Immunity. 2019;50(4):975–91.

Article  CAS  PubMed  Google Scholar 

Tapinos NI, Polihronis M, Tzioufas AG, Skopouli FN. Immunopathology of Sjogren’s syndrome. Ann Med Interne (Paris). 1998;149(1):17–24.

CAS  PubMed  Google Scholar 

Munkholm K, Vinberg M, Vedel Kessing L. Cytokines in bipolar disorder: a systematic review and meta-analysis. J Affect Disord. 2013;144(1–2):16–27.

Article  CAS  PubMed  Google Scholar 

Rosenblat JD. Targeting the immune system in the treatment of bipolar disorder. Psychopharmacology. 2019;236(10):2909–21.

Article  CAS  PubMed  Google Scholar 

Al-Alawi M, Al Sinawi H, Rashid R. In the realm of psychoneuroimmunology: the role of celecoxib as an add-on treatment for bipolar Mania. Mol Neuropsychiatry. 2018;4(3):164–7.

CAS  PubMed  PubMed Central  Google Scholar 

Berk M, Dean O, Cotton SM, Gama CS, Kapczinski F, Fernandes BS, Kohlmann K, Jeavons S, Hewitt K, Allwang C, et al. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord. 2011;135(1–3):389–94.

Article  CAS  PubMed  Google Scholar 

Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C, Smeraldi E. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP. Neurosci Lett. 2005;376(1):51–5.

Article  CAS  PubMed  Google Scholar 

Luca A, Calandra C, Luca M. Gsk3 signalling and redox status in bipolar disorder: evidence from lithium efficacy. Oxid Med Cell Longev. 2016;2016:3030547.

Article  PubMed  PubMed Central  Google Scholar 

Minton GO, Young AH, McQuade R, Fairchild G, Ingram CD, Gartside SE. Profound changes in dopaminergic neurotransmission in the prefrontal cortex in response to flattening of the diurnal glucocorticoid rhythm: implications for bipolar disorder. Neuropsychopharmacology. 2009;34(10):2265–74.

Article  CAS  PubMed  Google Scholar 

Spiliotaki M, Salpeas V, Malitas P, Alevizos V, Moutsatsou P. Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients. Psychoneuroendocrinology. 2006;31(6):748–60.

Article  CAS  PubMed  Google Scholar 

Xiao L, Xu H, Zhang Y, Wei Z, He J, Jiang W, Li X, Dyck LE, Devon RM, Deng Y, et al. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry. 2008;13(7):697–708.

Article  CAS  PubMed  Google Scholar 

Rossetti AC, Papp M, Gruca P, Paladini MS, Racagni G, Riva MA, Molteni R. Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: restorative effect of pharmacological intervention. Pharmacol Res. 2016;103:1–12.

Article  CAS  PubMed  Google Scholar 

Raison CL, Pikalov A, Siu C, Tsai J, Koblan K, Loebel A. C-reactive protein and response to lurasidone in patients with bipolar depression. Brain Behav Immun. 2018;73:717–24.

Article  CAS  PubMed  Google Scholar 

Ferrari M, Godio M, Martini S, Callegari C, Cosentino M, Marino F. Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder. Hum Psychopharmacol. 2022;37(6):e2854.

Article  CAS  PubMed  Google Scholar 

Miola A, Dal Porto V, Meda N, Perini G, Solmi M, Sambataro F. Secondary Mania induced by TNF-alpha inhibitors: a systematic review. Psychiatry Clin Neurosci. 2022;76(1):15–21.

Article  CAS  PubMed  Google Scholar 

Abrol E, Coutinho E, Chou M, Hart M, Vincent A, Howard R, Zandi MS, Isenberg D. Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre. Rheumatology (Oxford). 2021;60(12):5620–9.

Article  CAS  PubMed  Google Scholar 

De Berardis D, Serroni N, Campanella D, Olivieri L, Marini S, Moschetta FS, Martinotti G, Di Giannantonio M. Safety and efficacy of combined clozapine-azathioprine treatment in a case of resistant schizophrenia associated with Behcet’s disease: a 2-year follow-up. Gen Hosp Psychiatry. 2013;35(2):213 e219-211.

Article